newsfilter
← Latest News
GlobeNewswire·

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

MILAN and NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco